Catridecacog is recombinant human blood coagulation factor XIII analog.
Interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
B BLOOD AND BLOOD FORMING ORGANS
B02 ANTIHEMORRHAGICS
B02B VITAMIN K AND OTHER HEMOSTATICS
B02BD Blood coagulation factors
B02BD11 Catridecacog
D10532 Catridecacog (INN) <JP>
Therapeutic category of drugs in Japan [BR:br08301]
6 Agents against pathologic organisms and parasites
63 Biological preparations
634 Human blood preparations
6343 Plasma preparations
D10532 Catridecacog (INN); Catridecacog (genetical recombination) (JAN)
Drug groups [BR:br08330]
Blood modifier agent
DG02016 Hemostatics
DG02014 Blood coagulation accelerant
DG02013 Blood coagulation factor
D10532 Catridecacog
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D10532
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D10532